Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA, Haura E, Rodriguez FA, Boulware D, Kapoor R, Neuger AM, Lush R, Padilla B, Burton M, Williams C, Simon G, Antonia S, Sullivan DM, Bepler G. Chiappori AA, et al. Among authors: rodriguez fa. Clin Cancer Res. 2008 Mar 1;14(5):1464-9. doi: 10.1158/1078-0432.CCR-07-1508. Clin Cancer Res. 2008. PMID: 18316570 Clinical Trial.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Ko AH, Murphy PB, Peyton JD, Shipley DL, Al-Hazzouri A, Rodriguez FA, Womack MS 4th, Xiong HQ, Waterhouse DM, Tempero MA, Guo S, Lane CM, Earwood C, DeBusk LM, Bendell JC. Ko AH, et al. Among authors: rodriguez fa. Oncologist. 2017 Dec;22(12):1427-e129. doi: 10.1634/theoncologist.2017-0066. Epub 2017 Sep 21. Oncologist. 2017. PMID: 28935773 Free PMC article. Clinical Trial.
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.
Finkelstein SE, Rodriguez F, Dunn M, Farmello MJ, Smilee R, Janssen W, Kang L, Chuang T, Seigne J, Pow-Sang J, Torres-Roca JF, Heysek R, Biagoli M, Shankar R, Scott J, Antonia S, Gabrilovich D, Fishman M. Finkelstein SE, et al. Immunotherapy. 2012 Apr;4(4):373-82. doi: 10.2217/imt.12.24. Immunotherapy. 2012. PMID: 22512631 Free PMC article.
The RICA-2 registry: design and baseline characteristics of the first 1,000 patients.
Trullàs JC, Moreno-García MC, Mittelbrunn-Alquézar V, Conde-Martel A, Soler-Rangel L, Montero-Pérez-Barquero M, Casado J, Sánchez-Marteles M, Arévalo-Lorido JC, Pérez-Silvestre J; investigadores del registro RICA-2. Trullàs JC, et al. Rev Clin Esp (Barc). 2024 Oct;224(8):522-533. doi: 10.1016/j.rceng.2024.07.008. Epub 2024 Jul 23. Rev Clin Esp (Barc). 2024. PMID: 39053884
Physiological demands and motion analysis of elite foil fencing.
Bottoms L, Tarragó R, Muñiz D, Chaverri D, Irurtia A, Castizo-Olier J, Carrasco M, Rodríguez FA, Iglesias X. Bottoms L, et al. Among authors: rodriguez fa. PLoS One. 2023 Feb 14;18(2):e0281600. doi: 10.1371/journal.pone.0281600. eCollection 2023. PLoS One. 2023. PMID: 36787335 Free PMC article.
Maximum aerobic speed, maximum oxygen consumption, and running spatiotemporal parameters during an incremental test among middle- and long-distance runners and endurance non-running athletes.
Casado A, Tuimil JL, Iglesias X, Fernández-Del-Olmo M, Jiménez-Reyes P, Martín-Acero R, Rodríguez FA. Casado A, et al. Among authors: rodriguez fa. PeerJ. 2022 Oct 5;10:e14035. doi: 10.7717/peerj.14035. eCollection 2022. PeerJ. 2022. PMID: 36217384 Free PMC article.
119 results